With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment. Introducing the 4th iPSC Drug Development & Manufacturing Summit, your longest standing and definitive iPSC focused platform. No iPSC stone will be […]

SAE Media Group’s 5th Annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives. The conference will consider key developments in the wearable injectors field, including the enhanced […]

Are you listening to your patient community? It’s not enough. Standing in the shadows and harvesting anecdotal insights won’t build connections, create first-hand knowledge or illuminate your impact to internal stakeholders. We must step forward and be visible, actively engaging in patient communities and embedding the patient voice internally. YOU are the patient advocate in […]

Following the watershed approval of Iovance’s Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies Summit! With 30+ expert speakers, 12 new speaker companies, 2 brand-new content-filled tracks and 2 brand-new interactive workshops, you won't want to miss out! Hear […]

The 5th Commercializing Flow Chemistry Summit marks a pivotal year, introducing a significant shift in content to address the evolving needs of the pharmaceutical manufacturing industry. This summit zeroes in on advanced scale-up capabilities and stakeholder engagement strategies, responding to a market that is rapidly expanding and forecasted to reach US $4.6 billion by 2032. […]

𝘞𝘢𝘯𝘵 𝘵𝘰 𝘜𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥 𝘎𝘶𝘪𝘥𝘢𝘯𝘤𝘦, 𝘚𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘦 𝘚𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘴, & 𝘖𝘣𝘵𝘢𝘪𝘯 𝘈𝘱𝘱𝘳𝘰𝘷𝘢𝘭? The knowledge and connections you gain at the 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 will make the difference between success and delay in your IND and BLA applications. You'll hear from top regulatory experts like David Uguen (𝗢𝗿𝗰𝗵𝗮𝗿𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀), Shirley Bartido (𝗧𝗮𝗸𝗲𝗱𝗮 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀), Yao-Yao Zhu […]

With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degraders and many more assets. It has never been more import to re-join forces at the 7th TPD & Induced Proximity Summit, the longest standing and most comprehensive protein degradation and proximity based […]

Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace. The 6th Gene Therapy Analytical Development & CMC Summit […]

Spurred by George Schett and Andreas Mackensen’s remarkable CAR-T results in SLE, the immunotherapy revolution for autoimmune diseases is the next “million-dollar question”. The Autoimmunity Pharma & Biotech Partnering Summit is the only event of its kind, laying enabled partnering on top of hyper-relevant scientific discussion specifically for immune reset and reconstitution therapies. VIEW THE […]

Discover the future of drug discovery at the inaugural Hit ID Summit! As chemical libraries and hit screening methods—including DNA-encoded libraries, high-throughput screening, fragment-based screening, and AI—continue to evolve, now is the time for medicinal chemists, computational chemists, and drug discovery leaders and innovators to unite at a dedicated forum. This unique event presents the […]

The advanced therapy immuno-inflammatory dermatology market is undergoing unprecedented expansion, as Johnson & Johnson make a $3.35B play for bispecific candidates, Alumis secured $259M series C and Galderma, Incyte, and Eli Lilly unveil late-breaking data. With a fast-evolving drug development landscape, remaining at the forefront of promising targets is now more crucial than ever. That's […]

The Advanced Therapies Congress showcases the future of advanced therapies. Bringing Europe’s largest cell and gene therapy conference and exhibition to Philadelphia, the event is for the leaders of the world’s ATMP developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. This year, we will be expecting 1000+ […]

In the last 12 months, precision healthcare in the Asia-Pacific region has seen a surge in technology advancements, including NGS and laboratory developed tests, approvals such as a companion diagnostic test for lung cancer, and evolving regulations throughout the region. The World Companion Diagnostics & Liquid Biopsy Summit APAC has been put together to provide […]

Join us at the 2nd Donor Selection & Cell Source Summit - an unparalleled event dedicated to revolutionizing donor testing, screening, and cell source selection. This is your chance to be at the forefront of scalable allogeneic manufacturing and streamline both supply chain and process development. Why Attend? Dive Deep: Explore the latest global regulatory […]

The landmark FDA approval of the first MASH therapeutic, the orphan drug designation for systemic sclerosis trials, and the rapid advancement of IPF treatments through clinical phases have ignited a transformative era in fibrosis research. Now more than ever experts are doubling down on fibrosis. As the focus on innovative therapies intensifies, there is a […]

Mark your calendars for November because LEAP HR: Emerging Biopharma is back! Returning to Boston from November 19-20, this event is designed specifically for CHROs, CPOs, and Heads of HR at the heart of Emerging Biopharma organizations. Over the course of two days, we will unite the most senior leaders from Emerging Biopharma companies across […]

Join us at the inaugural Portfolio Strategy & Decision Making for Biopharma Summit - the must-attend event for pharma and biotech leaders seeking to sharpen their portfolio strategies in today’s dynamic market. Gain exclusive insights into leveraging advanced data analytics, forecasting tools, and innovative approaches to enhance decision-making. This summit will showcase real-world case studies […]

Liquid biopsies are revolutionizing clinical trials, emerging as a game-changing diagnostic tool for monitoring molecular residual disease and detecting disease resistance. This breakthrough enables precise patient stratification, ensuring they receive the most effective and safe treatments. The 3rd Liquid Biopsy Surveillance Summit returns as the leading East Coast forum solely dedicated to MRD detection in clinical trials […]

As structural biology tools and screening technologies advance, the GPCR super family continues to be a hot area of drug discovery, with the potential to treat a plethora of diseases. For the first time ever, the GPCRs-Targeted Drug Discovery Summit Europe is coming to London, with the aim of overcoming pharmacology challenges and advancing the […]

The 2nd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia bigger and better after last year’s explosive debut as the only meeting covering every aspect of bringing cell therapies to the autoimmune space. This year’s agenda brings you the opportunity to learn the A-Zs of accelerating your candidates to be the first in the market and finally bring the cure […]

As the field of cell therapy evolves, integrating the latest technologies and robust analytical methods has never been more crucial. Join us at the 6th Cell Therapy Analytical Development Summit to discover how to enhance your analytical strategies and accelerate product development through IND and clinical trials, leading to more efficient regulatory approval. Why Attend? […]

The Personalized Cancer Vaccine Summit (formerly known as the mRNA Cancer Vaccine Summit) returns to Boston bringing together the top industry players developing individualized approaches across several modalities including mRNA, DNA, peptides, viral, dendritic cell and more to share how they are conquering common challenges, developing novel bioinformatic strategies, and achieving clinical efficacy. This is […]

Just 11 years after Emmanuelle Charpentier and Jennifer Doudna’s seminal CRISPR discovery, Casgevy marks the first approved gene-editing therapy, a major milestone for the field. This breakthrough signals the beginning of a revolution in treating genetic diseases, with a rapidly growing pipeline of precision genome-editing techniques emerging. The 5th Genome Editing Therapeutics Summit (formerly the […]

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & Beyond The covalency renaissance continues as biopharma race to unlock hard-to-target proteins across oncology, immunology and CNS. Yet, key challenges remain in balancing reactivity and sensitivity, de-risking the ligandability of alternative […]

With recent accelerated approval wins, positive clinical trial readouts, progression through clinical pipelines and exciting mergers and acquisitions, it has certainly been an industry-defining year for the rare and genetic renal space. In the context of rapid progress and a mounting desire to propel game-changing novel therapies that will add to the arsenal of therapeutic […]

With Remix Therapeutics joining forces with Roche and Daiichi Sankyo partnering with Depixus, there have been many valuable collaborations entering the RNA-targeting field, accelerating efficacious and selective small molecules targeting RNA directly, RNA-binding proteins, and RNA/protein complexes. Hence, as the go-to meeting for the RNA-targeting small molecule community, the 7th Annual RNA-Targeted Drug Discovery & […]

With the community hailing the latest FDA-approved therapeutic with Novartis’ inhibitor of the alternative complement for PNH, which inhibitor will be the next to harness the complement system for the development of groundbreaking therapies? With assets in nephrology, ophthalmology, neurodegeneration, and inflammation all progressing through to the clinic, the immunology landscape is preparing to be […]

The 4th ADC Target Selection Summit returns to outline approaches to identify and validate novel targets that can be clinically and commercially successful and discuss rationale behind selecting a target to support with the development of future first-in-class ADCs. With sessions led by Almac Discovery, AstraZeneca, Bolt Biotherapeutics, and many other industry leaders, leave this […]

Join industry leaders like Eli Lilly, Merck, Novo Nordisk and Pfizer at the 4th Applied Biocatalysis & Enzyme Engineering Summit (December 10-12, 2024 – Philadelphia, PA). This is your perfect moment to network with enzyme discovery, engineering, biocatalysis, and process chemistry professionals from both industry and academia. Capitalize on Enzyme Evolution through HTP Screening, Advanced Engineering & […]

Join 100+ leading PAT scientists, engineers, process development, CMC, MSAT and quality experts at the 3rd Annual PAT & Real Time Quality Summit. Explore cutting-edge data-driven case studies, engage in dynamic roundtables and deep dive into KOL-led panel debates. This summit is your gateway to staying ahead of the innovation curve, exceeding stakeholder expectations for faster time to market, and unlocking significant […]